Zurich Insurance Group’s Quest Diagnostics DGX Stock Holding History

Zurich Insurance Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,500	Closed	-$2.25M	–	339
2026 Q1	$2.25M	Hold	11,500	–	–	0.02%	271
2025 Q4	$2M	Hold	11,500	–	–	0.01%	241
2025 Q3	$2.19M	Hold	11,500	–	–	0.02%	196
2025 Q2	$2.07M	Hold	11,500	–	–	0.02%	184
2025 Q1	$1.95M	Hold	11,500	–	–	0.02%	186
2024 Q4	$1.73M	Hold	11,500	–	–	0.01%	183
2024 Q3	$1.79M	Hold	11,500	–	–	0.02%	169
2024 Q2	$1.57M	Hold	11,500	–	–	0.01%	183
2024 Q1	$1.53M	Buy	+11,500	New	+$1.49M	0.01%	197
2022 Q3	–	Sell	-12,500	Closed	-$1.66M	–	232
2022 Q2	$1.66M	Hold	12,500	–	–	0.02%	147
2022 Q1	$1.71M	Hold	12,500	–	–	0.02%	139
2021 Q4	$2.16M	Hold	12,500	–	–	0.02%	118
2021 Q3	$1.82M	Hold	12,500	–	–	0.02%	134
2021 Q2	$1.65M	Hold	12,500	–	–	0.02%	154
2021 Q1	$1.6M	Hold	12,500	–	–	0.02%	145
2020 Q4	$1.49M	Buy	+12,500	New	+$1.52M	0.02%	139
2019 Q4	–	Sell	-26,363	Closed	-$2.82M	–	297
2019 Q3	$2.82M	Buy	+26,363	New	+$2.71M	0.05%	322
2017 Q4	–	Sell	-19,747	Closed	-$1.85M	–	577
2017 Q3	$1.85M	Sell	19,747 -753	-4%	-$79.9K	0.05%	394
2017 Q2	$2.28M	Sell	20,500 -11,788	-37%	-$1.25M	0.06%	360
2017 Q1	$3.17M	Sell	32,288 -14,536	-31%	-$1.39M	0.09%	264
2016 Q4	$4.3M	Buy	+46,824	New	+$4.04M	0.14%	200
2016 Q2	–	Sell	-13,200	Closed	-$943K	–	362
2016 Q1	$943K	Buy	+13,200	New	+$885K	0.03%	347

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Zurich Insurance Group's DGX Position: Q2 2026 in Review

Zurich Insurance Group sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 11,500 shares — an estimated $2.25M sold.

Zurich Insurance Group first reported a position in DGX in Q1 2016 and held it in 22 quarters. The position peaked at $4.3M in Q4 2016. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Zurich Insurance Group reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
Zurich Insurance Group sold 11,500 Quest Diagnostics shares in Q2 2026, an estimated $2.25M.
Zurich Insurance Group first reported a position in Quest Diagnostics in Q1 2016 and held it in 22 quarters.
Zurich Insurance Group's Quest Diagnostics position peaked at $4.3M in Q4 2016.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.